Celgene Restructures Jounce Alliance Amid BMS Acquisition
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 8 (Table of Contents)
Published: 1 Aug-2019
DOI: 10.3833/pdr.v2019.i8.2445 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
As its acquisition by Bristol-Myers Squibb (BMS) is underway, Celgene has agreed to restructure its July 2016 collaboration with Jounce Therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018